Researchers in China have found early evidence that Botox could help limit some of the most damaging effects of a snakebite, including severe muscle injury and inflammation.
The study, published in Toxicon, suggests that botulinum toxin, a compound widely known for cosmetic and pain treatment, may also work to reduce the body’s inflammatory response triggered by venom.
The research team, led by medical toxicologist Pin Lan at Lishui Central Hospital, tested this approach using venom from the Chinese moccasin, a venomous viper found in Asia. This species is known to cause significant muscle destruction through its bite.
In the lab, the team injected venom into the hind legs of rabbits and compared the results with a second group that received both venom and botulinum toxin. A control group was given only saline.
Early tests show Botox may limit tissue damage from snakebite
After 24 hours, researchers collected muscle samples and assessed the extent of damage. The rabbits treated with only venom showed over 30 percent swelling in the affected muscle.
In contrast, those who received Botox along with venom experienced almost no swelling. Muscle tissue death was also reduced in the group treated with the toxin.
The study also explored how Botox affected immune cells involved in inflammation. The researchers found fewer M1 macrophages, which are known to trigger inflammation, and more M2 macrophages, which promote tissue repair, in the toxin-treated group.
These changes suggest that the toxin may shift the immune response from a damaging phase to one focused on healing.
Global health impact of snakebites drives demand for new solutions
Snakebite remains a serious public health issue, killing more than 100,000 people each year worldwide and leaving many more with long-term disabilities, including limb loss. These outcomes are often linked to rapid swelling and tissue damage caused by venom.
David Williams, a herpetologist with the World Health Organization who was not part of the study, stressed the need for more investment in developing fast, effective treatments. He noted that antivenoms often fall short because they do not reverse local damage or reduce inflammation.
Ornella Rossetto, a neurobiologist at the University of Padua who also was not involved, pointed out that traditional antivenoms only neutralize venom in the bloodstream. They do not prevent the tissue breakdown that occurs at the bite site. She believes the findings could be an important step toward better therapies.
Both experts agree more research is needed before testing in humans, but the results open a new direction for treating venomous bites using Botox as part of medical care.
See all the latest news from Greece and the world at Greekreporter.com. Contact our newsroom to report an update or send your story, photos and videos. Follow GR on Google News and subscribe here to our daily email!
